中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2013年
22期
34-35
,共2页
惊恐障碍%帕罗西汀%黛力新
驚恐障礙%帕囉西汀%黛力新
량공장애%파라서정%대력신
Panic disorder%Paroxetine%Deanxit
目的：评价盐酸帕罗西汀联合黛力新治疗惊恐障碍的临床疗效及其不良反应。方法：将符合CCMD-3诊断标准的32倒惊恐障碍患者每日给予盐酸帕罗西汀10 mg和黛力新1片，连续治疗1个月，采用汉密尔顿焦虑量表(HAMA)和不良反应量表(TESS)评定疗效和药物不良反应。结果：32例患者均完成1个月的临床观察，总有效率为100%。HAMA总分及HAMA因子分(躯体性焦虑SA及精神性焦虑PA)治疗前后比较，差异均有统计学意义(P<0.01)，且患者不良反应轻微。结论：盐酸帕罗西汀联合黛力新治疗惊恐障碍安全有效，依从性好。
目的：評價鹽痠帕囉西汀聯閤黛力新治療驚恐障礙的臨床療效及其不良反應。方法：將符閤CCMD-3診斷標準的32倒驚恐障礙患者每日給予鹽痠帕囉西汀10 mg和黛力新1片，連續治療1箇月，採用漢密爾頓焦慮量錶(HAMA)和不良反應量錶(TESS)評定療效和藥物不良反應。結果：32例患者均完成1箇月的臨床觀察，總有效率為100%。HAMA總分及HAMA因子分(軀體性焦慮SA及精神性焦慮PA)治療前後比較，差異均有統計學意義(P<0.01)，且患者不良反應輕微。結論：鹽痠帕囉西汀聯閤黛力新治療驚恐障礙安全有效，依從性好。
목적：평개염산파라서정연합대력신치료량공장애적림상료효급기불량반응。방법：장부합CCMD-3진단표준적32도량공장애환자매일급여염산파라서정10 mg화대력신1편，련속치료1개월，채용한밀이돈초필량표(HAMA)화불량반응량표(TESS)평정료효화약물불량반응。결과：32례환자균완성1개월적림상관찰，총유효솔위100%。HAMA총분급HAMA인자분(구체성초필SA급정신성초필PA)치료전후비교，차이균유통계학의의(P<0.01)，차환자불량반응경미。결론：염산파라서정연합대력신치료량공장애안전유효，의종성호。
Objective:To evaluate the therapeutic and adverse effect of Paroxetine combined with Deanxit in the treatment of panic disorder.Methods:32 cases diagnosed as panic disorder according to CCMD-3 diagnostic criteria were treated with 10 mg Paroxetine and 1 tablet of Deanxit per day for 1 month.The therapeutic and adverse effects were evaluated by HAMA and TESS assessments.Results:Clinical observation of all cases was completed.The difference of HAMA score before and after treatment was significant(P<0.01).The total effective rate was 100%.The adverse effect of Paroxetine combined with Deanxit in the treatment of panic disorder was slight.Conclusion:Paroxetine combined with Deanxit therapy is safe,effective and good in compliance for the treatment of panic disorder.
